Compare OVBC & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OVBC | LFCR |
|---|---|---|
| Founded | 1872 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.9M | 190.9M |
| IPO Year | 1996 | 1996 |
| Metric | OVBC | LFCR |
|---|---|---|
| Price | $44.71 | $4.59 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 34.6K | ★ 122.1K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.22% | N/A |
| EPS Growth | ★ 42.67 | N/A |
| EPS | ★ 1.53 | N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.04 |
| P/E Ratio | $29.54 | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $34.18 | $3.63 |
| 52 Week High | $51.25 | $8.98 |
| Indicator | OVBC | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 58.55 | 50.36 |
| Support Level | $44.63 | $4.63 |
| Resistance Level | $47.12 | $5.21 |
| Average True Range (ATR) | 1.29 | 0.26 |
| MACD | 0.16 | 0.01 |
| Stochastic Oscillator | 75.52 | 46.10 |
Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services in Southeastern Ohio and western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers, and other standard banking products and services.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.